Prelude Therapeutics
(NASDAQ:PRLD)
$3.99
-0.05[-1.24%]
Last update: 10:27AM Get Real Time Here

Prelude Therapeutics Stock (NASDAQ:PRLD), Guidance and Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

No data available to display
Date Announced
ticker
Company Name
Period
Period Year
Min EPS
Max EPS
Estimate
Min Rev
Max Rev
Revenue Estimate
Get Alert

FAQ

Q

What is the most recent guidance for Prelude Therapeutics (PRLD)?

A

There have been no specific sales or earnings guidance reported for Prelude Therapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch